Filter News
Area of Research
- (-) Isotopes (7)
- (-) Nuclear Science and Technology (15)
- Advanced Manufacturing (5)
- Biological Systems (1)
- Biology and Environment (25)
- Clean Energy (94)
- Computational Biology (2)
- Computational Engineering (1)
- Computer Science (1)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (12)
- Fusion Energy (8)
- Isotope Development and Production (1)
- Materials (94)
- Materials Characterization (1)
- Materials for Computing (18)
- Materials Under Extremes (1)
- National Security (8)
- Neutron Science (39)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Supercomputing (40)
- Transportation Systems (2)
News Topics
- (-) Advanced Reactors (11)
- (-) Biomedical (7)
- (-) Materials Science (5)
- 3-D Printing/Advanced Manufacturing (4)
- Bioenergy (1)
- Climate Change (1)
- Computer Science (3)
- Coronavirus (1)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (1)
- Environment (2)
- Fusion (8)
- Irradiation (1)
- Isotopes (29)
- Materials (4)
- Molten Salt (4)
- National Security (1)
- Neutron Science (5)
- Nuclear Energy (39)
- Physics (2)
- Security (1)
- Space Exploration (9)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
With the production of 50 grams of plutonium-238, researchers at the Department of Energy’s Oak Ridge National Laboratory have restored a U.S. capability dormant for nearly 30 years and set the course to provide power for NASA and other missions.